Evidence map›Paper›PMID 32115421›Full record

ArticleAJNR. American journal of neuroradiology2020

The FRED for Cerebral Aneurysms of the Posterior Circulation: A Subgroup Analysis of the EuFRED Registry.

C J Griessenauer, M A Möhlenbruch, P Hendrix, C Ulfert, C Islak, M Sonnberger, T Engelhorn, E Müller-Thies-Broussalis, T Finkenzeller, M Holtmannspötter and 6 more

Open access · hybridAbstract read
In one paragraph

Article in AJNR. American journal of neuroradiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Flow redirection endoluminal device (FRED) for treatment of intracranial aneurysms: A systematic review.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2022
    Pooled it
  3. Review
  4. Flow diversion in the treatment of intracranial aneurysms using the novel FRED X device: An early experience from a single high-volume center.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2025
    Article
  5. Article
  6. Article
  7. Retrospective analysis of intracranial aneurysms after flow diverter treatment including color-coded imaging (syngo iFlow) as a predictor of aneurysm occlusion.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2022
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 12 institutions in 4 countries.

C J GriessenauerFrom the Research Institute of Neurointervention (C.J.G., E.M.-T.-B., M.K.-O.), Paracelsus Medical University, Salzburg, Austria christoph.griessenauer@gmail.com.ORCID 0000-0002-2952-3812
M A MöhlenbruchDepartment of Neuroradiology (M.A.M., C.U.), Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0002-5075-704X
P HendrixDepartment of Neurosurgery (P.H.), Saarland University Medical Center and Saarland University Faculty of Medicine, Homburg/Saar, Germany.ORCID 0000-0003-0017-5049
C UlfertDepartment of Neuroradiology (M.A.M., C.U.), Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0003-3642-350X
C IslakDepartment of Neuroradiology (C.I., N.K.), Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey.ORCID 0000-0002-3626-6244
M SonnbergerDepartment of Neuroradiology (M.S.), Kepler Universitätsklinikum, Linz, Austria.ORCID 0000-0001-9899-694X
T EngelhornDepartment of Neuroradiology (T.E.), University Hospital Erlangen, Erlangen, Germany.ORCID 0000-0001-7341-3584
E Müller-Thies-BroussalisFrom the Research Institute of Neurointervention (C.J.G., E.M.-T.-B., M.K.-O.), Paracelsus Medical University, Salzburg, Austria.ORCID 0000-0003-0484-2427
T FinkenzellerInstitute of Radiology and Neuroradiology (T.F., M.H.), Klinikum Nuernberg Sued, Paracelsus Medical University, Nuernberg, Germany.ORCID 0000-0001-9637-9497
M HoltmannspötterInstitute of Radiology and Neuroradiology (T.F., M.H.), Klinikum Nuernberg Sued, Paracelsus Medical University, Nuernberg, Germany.ORCID 0000-0003-2536-5244
J-H BuhkDepartment of Neuroradiology (J.-H.B.), University Hospital Hamburg Eppendorf, Hamburg, Germany.ORCID 0000-0002-8003-6446
W ReithClinic for Diagnostic and Interventional Neuroradiology (W.R., A.S.), Universitätsklinikum des Saarlandes, Homburg/Saar, Homburg, Saarland, Germany.ORCID 0000-0001-8373-4090
A SimgenClinic for Diagnostic and Interventional Neuroradiology (W.R., A.S.), Universitätsklinikum des Saarlandes, Homburg/Saar, Homburg, Saarland, Germany.ORCID 0000-0003-0913-6740
H JanssenInstitute for Neuroradiology (H.J.), Klinikum Ingolstadt, Ingolstadt, Germany.ORCID 0000-0001-5903-1280
N KocerDepartment of Neuroradiology (C.I., N.K.), Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey.ORCID 0000-0003-0884-6492
M Killer-OberpfalzerFrom the Research Institute of Neurointervention (C.J.G., E.M.-T.-B., M.K.-O.), Paracelsus Medical University, Salzburg, Austria.ORCID 0000-0001-5572-7694
Heidelberg University · DEIstanbul University-Cerrahpaşa · TRParacelsus Medical University · ATUniversitätsklinikum des Saarlandes · DEGeisinger Medical Center · USKepler Universitätsklinikum · ATKlinikum Ingolstadt · DEKlinikum Weiden · DEParacelsus Medizinische Privatuniversität · DESaarland University · DEUniversität Hamburg · DEUniversitätsklinikum Erlangen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeFlow diversion for the posterior circulation remains a promising treatment option for selected posterior circulation aneurysms. The Flow-Redirection Intraluminal Device (FRED) system has not been previously assessed in a large cohort of patients with posterior circulation aneurysms. The purpose of the present study was to assess safety and efficacy of FRED in this location. MATERIALS AND

methodsConsecutive patients with posterior circulation aneurysms treated at 8 centers participating in the European FRED study (EuFRED) between April 2012 and January 2019 were retrospectively reviewed. Complication and radiographic and functional outcomes were evaluated.

resultsEighty-four patients (median age, 54 years) with 84 posterior circulation aneurysms were treated with the FRED. A total of 25 aneurysms (29.8%) had previously ruptured, even though most aneurysms were diagnosed incidentally (45.2%). The intradural vertebral artery was the most common location (50%), and saccular, the most common morphology (40.5%). The median size was 7 mm. There were 8 (9.5%) symptomatic thromboembolic and no hemorrhagic complications. Thromboembolic complications occurred mostly (90.9%) in nonsaccular aneurysms. On last follow-up at a median of 24 months, 78.2% of aneurysms were completely occluded. Functional outcome at a median of 27 months was favorable in 94% of patients. All mortalities occurred in patients with acute subarachnoid hemorrhage and its sequelae.

conclusionsThe largest cohort of posterior circulation aneurysms treated with the FRED to date demonstrated favorable safety and efficacy profiles of the device for this indication. Treatment in the setting of acute subarachnoid hemorrhage was strongly related to mortality, regardless of whether procedural complications occurred.

Indexed as

AdultAgedCohort StudiesEmbolization, TherapeuticEndovascular ProceduresFemaleHumansIntracranial AneurysmMaleMiddle AgedPostoperative ComplicationsRegistriesRetrospective StudiesStentsTreatment Outcome

Identifiers

PMID32115421
PMCPMC7144644
OpenAlexW3007558289

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.